Assignee
VIVUS INC
US·38 granted patents·55 pending applications·2,333 citations·filing 1993–2021
Top patents by PatentIndex Score
93 records- 0199US7226910B2Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonistsVIVUS INC·Filed 2005·Granted Jun 5, 2007·103 cites·23 claims
- 0297US6472434B1Method for minimizing excess collagen depositionVIVUS INC·Filed 2000·Granted Oct 29, 2002·110 cites·32 claims
- 0397US6469016B1Treatment of female sexual dysfunction using phosphodiesterase inhibitorsVIVUS INC·Filed 2000·Granted Oct 22, 2002·148 cites·64 claims
- 0497US6037346ALocal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunctionVIVUS INC·Filed 1998·Granted Mar 14, 2000·224 cites·94 claims
- 0597US5877216ATreatment of female sexual dysfunctionVIVUS INC·Filed 1997·Granted Mar 2, 1999·333 cites·25 claims
- 0696US6593313B2Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunctionVIVUS INC·Filed 2001·Granted Jul 15, 2003·72 cites·69 claims
- 0796US6495154B1On demand administration of clomipramine and salts thereof to treat premature ejaculationVIVUS INC·Filed 2000·Granted Dec 17, 2002·104 cites·71 claims
- 0895US7553818B2Combination therapy for effecting weight loss and treating obesityVIVUS INC·Filed 2006·Granted Jun 30, 2009·23 cites·24 claims
- 0995US6403597B1Administration of phosphodiesterase inhibitors for the treatment of premature ejaculationVIVUS INC·Filed 2001·Granted Jun 11, 2002·166 cites·94 claims
- 1094US7674776B2Combination therapy for effecting weight loss and treating obesityVIVUS INC·Filed 2006·Granted Mar 9, 2010·28 cites·59 claims
- 1194US7659256B2Combination therapy for effecting weight loss and treating obesityVIVUS INC·Filed 2006·Granted Feb 9, 2010·22 cites·29 claims
- 1294US6127363ALocal administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunctionVIVUS INC·Filed 1999·Granted Oct 3, 2000·136 cites·106 claims
- 1392US7056890B2Combination therapy for effecting weight loss and treating obesityVIVUS INC·Filed 2003·Granted Jun 6, 2006·47 cites·54 claims
- 1492US6156753ALocal administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunctionVIVUS INC·Filed 1999·Granted Dec 5, 2000·113 cites·67 claims
- 1592US5474535ADosage and inserter for treatment of erectile dysfunctionVIVUS INC·Filed 1993·Granted Dec 12, 1995·92 cites·21 claims
- 1691US8895058B2Low dose topiramate/phentermine composition and methods of use thereofVIVUS INC·Filed 2013·Granted Nov 25, 2014·9 cites·32 claims
- 1791US5922341ALocal administration of pharmacologically active agents to treat premature ejaculationVIVUS INC·Filed 1997·Granted Jul 13, 1999·102 cites·80 claims
- 1890US8895057B2Escalating dosing regimen for effecting weight loss and treating obesityVIVUS INC·Filed 2013·Granted Nov 25, 2014·8 cites·33 claims
- 1989US9011905B2Low dose topiramate/phentermine composition and methods of use thereofVIVUS INC·Filed 2014·Granted Apr 21, 2015·6 cites·38 claims
- 2088US6593369B2Methods, compositions, and kits for enhancing female sexual desire and responsivenessVIVUS INC·Filed 2001·Granted Jul 15, 2003·23 cites·15 claims
- 2187US9011906B2Escalating dosing regimen for effecting weight loss and treating obesityVIVUS INC·Filed 2014·Granted Apr 21, 2015·5 cites·31 claims
- 2287US6946141B2As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculationVIVUS INC·Filed 2001·Granted Sep 20, 2005·24 cites·68 claims
- 2387US6548490B1Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunctionVIVUS INC·Filed 1999·Granted Apr 15, 2003·54 cites·51 claims
- 2487US6228864B1Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculationVIVUS INC·Filed 1998·Granted May 8, 2001·68 cites·18 claims
- 2585US10058532B2Methods of preventing progression to type 2 diabetes mellitusVIVUS INC·Filed 2017·Granted Aug 28, 2018·3 cites·16 claims
- 2683US9724327B2Methods of preventing progression to type 2 diabetes mellitusVIVUS INC·Filed 2014·Granted Aug 8, 2017·4 cites·17 claims
- 2781US10028916B2Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and useVIVUS INC·Filed 2015·Granted Jul 24, 2018·3 cites·13 claims
- 2875US5820587AMethod and kit for preventing erectile dysfunctionVIVUS INC·Filed 1997·Granted Oct 13, 1998·37 cites·59 claims
- 2973US2020188352A1Escalating dosing regimen for effecting weight loss and treating obesityVIVUS INC·Filed 2020·Application pending·0 cites
- 3073US2020188313A1Low dose topiramate/phentermine composition and methods of use thereofVIVUS INC·Filed 2020·Application pending·0 cites
- 3172US2021161932A1Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonistVIVUS INC·Filed 2021·Application pending·0 cites
- 3271US2020129474A1Combination therapy for effecting weight loss and treating obesityVIVUS INC·Filed 2020·Application pending·0 cites
- 3371US2019350866A1Low dose topiramate/phentermine composition and methods of use thereofVIVUS INC·Filed 2018·Application pending·0 cites
- 3470US2019350897A1Escalating dosing regimen for effecting weight loss and treating obesityVIVUS INC·Filed 2018·Application pending·0 cites
- 3569US5925629ATransurethral administration of androgenic agents for the treatment of erectile dysfunctionVIVUS INC·Filed 1997·Granted Jul 20, 1999·32 cites·26 claims
- 3669US5773020ATreatment of erectile dysfunctionVIVUS INC·Filed 1997·Granted Jun 30, 1998·72 cites·18 claims
- 3768US2021283096A1Methods of treating obesity in responder and non-responder populationsVIVUS INC·Filed 2021·Application pending·0 cites
- 3867US2020135318A1Methods of regulating access to qsymia to mitigate potential drug-associated risksVIVUS INC·Filed 2020·Application pending·0 cites
- 3967US2021338642A1Compositions and methods for the treatment or prevention of pulmonary hypertensionVIVUS INC·Filed 2021·Application pending·0 cites
- 4067US2020030239A1Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and useVIVUS INC·Filed 2019·Application pending·0 cites
- 4167US2019350864A1Pharmaceutical formulationsVIVUS INC·Filed 2018·Application pending·0 cites
- 4267US2019139635A1Methods of regulating access to qsymia to mitigate potential drug-associated risksVIVUS INC·Filed 2018·Application pending·0 cites
- 4367US2014288944A1Methods of regulating access to qsymia to mitigate potential drug-associated risksVIVUS INC·Filed 2014·Application pending·0 cites
- 4466US2020069658A1Combination therapy for pulmonary hypertensionVIVUS INC·Filed 2019·Application pending·0 cites
- 4566US2021267951A1Combination therapy for pulmonary hypertensionVIVUS INC·Filed 2021·Application pending·0 cites
- 4666US2014294950A1Methods of treating obesity in responder and non-responder populationsVIVUS INC·Filed 2014·Application pending·0 cites
- 4766US2019167633A1Combination therapy for effecting weight loss and treating obesityVIVUS INC·Filed 2018·Application pending·0 cites
- 4866US2015025134A1Compositions and Methods for the Treatment of Sleep ApneaVIVUS INC·Filed 2014·Application pending·0 cites
- 4965US2019142786A1Methods of treating obesity in responder and non-responder populationsVIVUS INC·Filed 2018·Application pending·0 cites
- 5065US2014308346A1Combination therapy for effecting weight loss and treating obesityVIVUS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 93 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →